EHA – 2023 – Poster Presentation P1396
Publications
June 9, 2023
CD33-Deleted Hematopoietic Stem and Progenitor Cells Display Normal Engraftment after Hematopoietic Cell Transplant (HCT) and Tolerate Post-HCT GemtuzumabOzogamicin(GO) Without Cytopenias
Trem-cel
Presented by: Guenther Koehne, MD, PhD – Miami Cancer Institute | Baptist Health South Florida